AFEYAN NOUBAR
Related Filers (68)
- Moderna, Inc. (97)
- KANIA EDWIN M JR (58)
- Flagship Ventures Fund IV General Partner LLC (43)
- Flagship Ventures Fund IV, L.P. (43)
- Flagship Pioneering Inc. (35)
- Flagship Ventures Fund IV-Rx, L.P. (31)
- Flagship Ventures Fund 2007, L.P. (27)
- Flagship Ventures 2007 General Partner LLC (27)
- Flagship Ventures Fund V, L.P. (22)
- Flagship Ventures Fund V General Partner LLC (20)
- BG Medicine, Inc. (19)
- Flagship Ventures Opportunities Fund I, L.P. (19)
- NewcoGen Group, Inc. (18)
- ANTIGENICS INC /DE/ (17)
- Flagship Ventures Opportunities Fund I General Partner LLC (17)
- Flagship VentureLabs IV, LLC (13)
- Flagship V VentureLabs Rx Fund, L.P. (12)
- Seres Therapeutics, Inc. (11)
- HELICOS BIOSCIENCES CORP (10)
- Flagship Ventures Fund 2004 L P (9)
- Flagship Ventures General Partner LLC (9)
- Nutritional Health LTP Fund General Partner LLC (9)
- Nutritional Health LTP Fund, L.P. (9)
- NewcoGen PE LLC (8)
- NEWCOGEN GROUP LLC (8)
- NEWCOGEN EQUITY INVESTORS LLC (8)
- Eleven Biotherapeutics, Inc. (8)
- Rubius Therapeutics, Inc. (8)
- Flagship Pioneering Special Opportunities Fund II General Partner LLC (8)
- Flagship Pioneering Special Opportunities Fund II, L.P. (8)
- Flagship VentureLabs V LLC (8)
- NewcoGen Elan LLC (7)
- ST NewcoGen LLC (7)
- Evelo Biosciences, Inc. (7)
- Sana Biotechnology, Inc. (6)
- Kaleido Biosciences, Inc. (6)
- Omega Therapeutics, Inc. (6)
- Flagship VentureLabs V Manager LLC (6)
- Flagship Pioneering Fund VI General Partner LLC (6)
- Flagship Pioneering Fund VI, L.P. (6)
- NewcoGen Long Reign Holding LLC (5)
- AGTC Partners, L.P. (5)
- Axcella Health Inc. (5)
- AGTC ADVISORS FUND LP (4)
- Applied Genomic Technology Capital Fund LP (4)
- Syros Pharmaceuticals, Inc. (4)
- Nutritional Health Side Fund, L.P. (4)
- Nutritional Health Disruptive Innovation Fund, L.P. (4)
- Receptos, Inc. (3)
- AGIOS PHARMACEUTICALS INC (3)
- Editas Medicine, Inc. (3)
- TransMedics Group, Inc. (3)
- Codiak BioSciences, Inc. (3)
- Sigilon Therapeutics, Inc. (3)
- TETRAPHASE PHARMACEUTICALS INC (2)
- BIND Therapeutics, Inc (2)
- CONCERT PHARMACEUTICALS, INC. (2)
- T2 Biosystems, Inc. (2)
- SELECTA BIOSCIENCES INC (2)
- Denali Therapeutics Inc. (2)
- Quanterix Corp (2)
- Cadena LLC (2)
- Foghorn Therapeutics Inc. (2)
- FPN, L.P. (2)
- FPN General Partner LLC (2)
- ACCELERON PHARMA INC (1)
- Flagship Pioneering Fund VII, L.P. (1)
- Flagship Pioneering Fund VII General Partner LLC (1)
- Show More ...
Other (38)
13F-NT
Wednesday, 2/14/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
144
Wednesday, 11/1/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 10/25/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 10/11/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 10/4/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/27/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/20/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/13/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/6/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/30/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/23/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/16/2023
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
144
Wednesday, 8/2/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 7/26/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 7/19/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 7/12/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 7/5/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/28/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/21/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/14/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/7/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 5/31/2023
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/16/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 8/13/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 5/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 2/13/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (218)
4
Wednesday, 2/14/2024
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/3/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/27/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/13/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/6/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/29/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/22/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/15/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/15/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/1/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/25/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/4/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/28/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/21/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/14/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/13/2023
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/30/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/26/2023
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/5/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/24/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/10/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/27/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/13/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2023
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/23/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/9/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/25/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/18/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/10/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/21/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/17/2022
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/14/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/7/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/30/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/23/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2022
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/9/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/19/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/12/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/5/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/29/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/22/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/15/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/15/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/8/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/7/2022
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/13/2022
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/13/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/2/2022
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
Axcella Health Inc.: Statement of changes in beneficial ownership of securities
5
Monday, 2/14/2022
Moderna, Inc.: Annual statement of changes in beneficial ownership of securities
4
Thursday, 8/5/2021
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/30/2021
Omega Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Omega Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/19/2021
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/13/2021
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/30/2021
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/31/2021
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/23/2021
Rubius Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/24/2021
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/24/2021
Moderna, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/10/2021
Sana Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/10/2021
Kaleido Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2021
Evelo Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/3/2021
Sana Biotechnology, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/10/2020
Sigilon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Sigilon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 11/25/2020
Seres Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/29/2020
Foghorn Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/22/2020
Foghorn Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/20/2020
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/13/2020
Codiak BioSciences, Inc.: Initial statement of beneficial ownership of securities